Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Homogenous BTK occupancy assay used in tirabrutinib clinical studies

Homogenous BTK occupancy assay used in tirabrutinib clinical studies

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Scientists discover new way to predict healthy individuals at risk of developing AML

Scientists discover new way to predict healthy individuals at risk of developing AML

Altitude sickness drug may offer significant gains for patients with glioblastoma

Altitude sickness drug may offer significant gains for patients with glioblastoma

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

Drug used in stem cell therapy may protect against smoke-induced lung injury

Drug used in stem cell therapy may protect against smoke-induced lung injury

Streamlining and translating basic science discoveries into the clinic

Streamlining and translating basic science discoveries into the clinic

AbbVie and Calibr collaborate to develop T-cell therapies aimed at cancer

AbbVie and Calibr collaborate to develop T-cell therapies aimed at cancer

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors

Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors

Study: Oxidative stress can be used against tumors to treat cancer

Study: Oxidative stress can be used against tumors to treat cancer

Clinical trial targets metastatic colorectal cancer with new combination therapy

Clinical trial targets metastatic colorectal cancer with new combination therapy

Drug used to treat myelofibrosis can awaken ‘dormant’ lymphomas in the bone marrow

Drug used to treat myelofibrosis can awaken ‘dormant’ lymphomas in the bone marrow

Some tumors use two levels of protection against immune system, shows study

Some tumors use two levels of protection against immune system, shows study

Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

Miniaturized device offers new way to gain insight into cell processes and communication

Miniaturized device offers new way to gain insight into cell processes and communication